Miller P Elliott, Senman Balimkiz C, Gage Ann, Carnicelli Anthony P, Jacobs Mark, Rali Aniket S, Senussi Mourad H, Bhatt Ankeet S, Hollenberg Steven M, Kini Annapoorna, Menon Venu, Grubb Kendra J, Morrow David A
Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Division of Cardiology, Duke University, Durham, North Carolina, USA.
JACC Adv. 2024 Dec 26;3(12):101402. doi: 10.1016/j.jacadv.2024.101402. eCollection 2024 Dec.
Acute decompensated valvular disease encompasses a group of complex and challenging conditions, which are often the primary reason for admission to the cardiac intensive care unit and can also complicate the management of other primary cardiac disorders. Critically ill patients with valvular disease also present unique diagnostic and management challenges. Historically, medical and percutaneous interventional therapies have been limited and surgery was the only definitive treatment; however, surgical risk can at times be prohibitive. High-quality evidence to direct management of acute valvular disorders in this population is lacking and societal guidelines largely do not address treatment options for critically ill patients with decompensated valvular disease. In this review, we discuss the clinical presentation and epidemiology of commonly encountered valvular diseases in the modern cardiac intensive care unit, highlight key pathophysiology, detail gaps in evidence, describe the pivotal role of multidisciplinary Heart Teams, and provide guidance for management.
急性失代偿性瓣膜病涵盖了一组复杂且具有挑战性的病症,这些病症常常是入住心脏重症监护病房的主要原因,也会使其他原发性心脏疾病的治疗复杂化。患有瓣膜病的危重症患者还面临独特的诊断和管理挑战。从历史上看,药物和经皮介入治疗一直有限,手术是唯一的确定性治疗方法;然而,手术风险有时可能过高。缺乏指导该人群急性瓣膜病管理的高质量证据,社会指南在很大程度上也未涉及失代偿性瓣膜病危重症患者的治疗选择。在本综述中,我们讨论现代心脏重症监护病房中常见瓣膜病的临床表现和流行病学,强调关键病理生理学,详述证据空白,描述多学科心脏团队的关键作用,并提供管理指导。